NYSE:PMTobacco
A Look At Philip Morris International’s Valuation As Smoke Free Shift And FDA ZYN Bid Take Center Stage
Philip Morris International (PM) is in the spotlight as it pushes further into smoke-free products, seeking FDA modified risk status for ZYN while reshaping its operations through job cuts, office closures and centralized hubs.
See our latest analysis for Philip Morris International.
Against this backdrop of restructuring and the push for smoke free products, Philip Morris International’s share price has climbed to US$179.94, with a 30 day share price return of 12.25% and a 1 year total...